华大基因(300676) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was ¥821,250,378.55, a decrease of 14.00% compared to ¥954,886,929.14 in the same period last year[3] - Net profit attributable to shareholders was ¥12,402,522.05, down 69.91% from ¥41,213,517.51 in the previous year[3] - The company achieved operating revenue of RMB 821.25 million, a year-on-year decrease of 14.00%[14] - The net profit attributable to shareholders was RMB 12.40 million, down 69.91% year-on-year[14] - The decline in performance was primarily due to a decrease in operating revenue and slower collection of accounts receivable, leading to increased credit impairment losses compared to the previous year[14] - Total operating revenue for Q1 2024 was CNY 821,250,378.55, a decrease of 13.9% compared to CNY 954,886,929.14 in the same period last year[19] - Net profit for Q1 2024 was CNY 12,150,258.43, a decline of 70.5% compared to CNY 41,201,935.95 in Q1 2023[20] - Basic earnings per share for Q1 2024 were CNY 0.0303, down from CNY 0.0908 in Q1 2023[21] Cash Flow and Assets - The net cash flow from operating activities was -¥75,937,361.58, a decline of 453.74% compared to ¥21,467,056.73 in the same period last year[3] - Total current assets decreased from 7,932,793,311.89 yuan to 7,847,995,249.89 yuan, a decline of approximately 1.06%[18] - Total assets at the end of the reporting period were ¥13,457,042,775.66, a decrease of 1.15% from ¥13,613,007,886.01 at the end of the previous year[4] - The cash and cash equivalents at the end of the period stand at 2,910,899,148.83 RMB, down from 5,304,950,019.15 RMB[23] - The company reported a significant decrease in cash received from operating activities, with a drop of over 50% in both cash inflows and outflows compared to the previous period[23] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 67,851[8] - The largest shareholder, Shenzhen BGI Technology Co., Ltd., holds 35.94% of the shares, totaling 148,773,893 shares[8] - The top 10 shareholders include Shenzhen BGI Investment Enterprise (Limited Partnership) holding 34,470,455 shares, representing 8.43% of total shares[10] - Wang Jian, the controlling shareholder, holds 2,537,800 shares, which is 0.61% of total shares[10] - As of the report date, the controlling shareholder holds 155,247,517 shares, accounting for 37.51% of the total share capital, with 88.56 million shares pledged, representing 57.04% of their holdings and 21.40% of the total share capital[15] Investment and Expenses - The company reported a significant decrease in investment income, with a loss of ¥1,245,924.99 compared to a profit of ¥32,549,504.33 in the previous year, marking a 103.83% decline[7] - Research and development expenses for Q1 2024 amounted to CNY 106,372,298.63, a decrease of 12.8% from CNY 122,054,639.38 in the previous year[20] - The company reported a decrease in sales expenses to CNY 169,892,501.64 from CNY 224,191,696.92 in the previous year, reflecting a reduction of 24.2%[20] Operational Challenges - The first quarter report indicates that the company is facing challenges in revenue growth and profitability[14] - The company reported an increase in credit impairment losses due to the overall economic environment affecting receivables collection[14] - The company has not disclosed any new product developments or market expansion strategies in the report[14] - There are no significant mergers or acquisitions mentioned in the current report[14] - The company continues to explore new strategies for market expansion and product development, although specific figures were not disclosed in the report[15] - The financial report indicates a stable operational environment, with ongoing assessments of shareholder equity and funding strategies to enhance liquidity and operational efficiency[16] Liabilities and Equity - Total liabilities as of Q1 2024 were CNY 3,413,525,388.13, a decrease from CNY 3,608,987,599.21 in the previous year[19] - Total equity attributable to shareholders of the parent company was CNY 9,899,998,533.77, an increase from CNY 9,859,237,734.19 year-over-year[19] Miscellaneous - The company received government subsidies amounting to ¥12,162,258.55 during the reporting period[5] - The company has not undergone an audit for the first quarter report[25]